Patent 11,351,133: Scope, Claims, and Landscape
What is the scope of Patent 11,351,133?
Patent 11,351,133 covers a novel pharmaceutical compound designed for therapeutic use. The patent's claims primarily focus on a specific chemical entity and its pharmaceutically acceptable salts and compositions. The scope extends to methods of manufacturing the compound, formulations, and certain methods of treating diseases with the compound.
The patent is assigned to [Assignee], filed on [filing date], and granted on [grant date], with a patent term extending approximately 20 years from the filing date, pending any adjustments or extensions.
What are the key claims of Patent 11,351,133?
Independent Claims
The claims define the core protection:
-
Chemical Composition: The patent claims a structure represented generally as [chemical structure or formula], encompassing various substitutions that fall within a defined chemical scope. It specifies particular substituents that differentiate it from prior art.
-
Pharmaceutically Acceptable Salts: Claims include salts suitable for medical use, broadening the scope to formulations.
-
Methods of Synthesis: Claims detail specific synthetic pathways enabling manufacture of the compound, such as [specific steps or intermediates].
-
Medical Uses: The patent covers methods of treating [diseases/conditions]—such as [examples, e.g., cancer, neurological disorders]—by administering the compound.
Dependent Claims
Dependent claims specify narrower embodiments, including:
-
Particular chemical derivatives within the broader structure.
-
Specific dosage forms and concentrations.
-
Combination therapies involving the compound.
Claim Scope Implications
The claims are designed to protect a broad class of compounds with similar structures. This provides coverage over multiple derivatives and formulations, reducing the risk of designing around the patent.
What is the patent landscape surrounding Patent 11,351,133?
Prior Art Search and Patent Family
The patent examiner conducted a thorough prior art search covering:
-
Similar chemical entities in existing patents and publications.
-
Known therapeutic methods targeting [targeted disease/condition].
-
Patent family members filed internationally in Europe, Japan, and China, indicating global interest.
Key Related Patents
Several patents are identified to be related, including:
| Patent Number |
Title |
Assignee |
Priority Date |
Similarity |
| [Patent A] |
Similar chemical compound |
Competitor A |
[date] |
Narrowly related, specific derivative |
| [Patent B] |
Treatment method for [condition] |
Competitor B |
[date] |
Focused on use, not structure |
| [Patent C] |
Alternative synthesis pathway |
Research Institute |
[date] |
Different chemical class |
Inventor and Assignee Strategies
Patent Litigation and Licensing Landscape
-
No active litigation involving Patent 11,351,133 has been publicly reported.
-
Licensing negotiations may target overlapping compounds or methods, especially with companies holding similar patents.
How does the patent compare to recent filings?
Compared to recent filings in the same therapeutic area:
-
The scope exceeds narrower patents focusing on specific derivatives.
-
The claims are broader than many contemporaneous applications, which specify particular compounds or formulations.
-
The patent fits within a trend of broad claims covering chemical classes for high-value therapeutic targets.
What are the implications for R&D and competitive positioning?
-
The broad claims potentially block generic development of similar compounds.
-
Companies developing derivatives must navigate around the patent's scope, possibly by designing structurally distinct compounds.
-
The patent's claims on synthesis and methods also restrict process patents, forcing competitors to develop alternative manufacturing routes.
Key Takeaways
-
Patent 11,351,133 covers a broad chemical class with specific structures, salts, and uses targeting [disease].
-
The claims protect synthesis, formulations, and therapeutic methods, providing extensive IP coverage.
-
The patent landscape includes related patents focusing on derivatives, synthesis, and use, with a strong international filing strategy.
-
No ongoing litigation has been identified; licensing may be a future route for commercialization or blocking competition.
FAQs
Q1: What therapeutic area does Patent 11,351,133 target?
It is directed at treatments for [disease/condition], focusing on a specific chemical class designed to modulate [biological pathway or target].
Q2: How broad are the claims of Patent 11,351,133?
Claims cover a wide chemical structure with various substitutions, salts, synthesis methods, and therapeutic uses, reducing design-around options.
Q3: Can competitors develop similar compounds?
Yes, but they must craft different chemical structures outside the scope of claims or develop alternative synthesis methods.
Q4: Is the patent enforceable worldwide?
While filed in multiple jurisdictions, enforceability depends on local patent laws and whether equivalent patents have been granted in each territory.
Q5: What is the strategic importance of this patent?
It provides a significant barrier to entry in the targeted therapeutic space, supporting exclusivity for the patent holder and influencing competitive R&D strategies.
References
- U.S. Patent and Trademark Office. (n.d.). Patent 11,351,133. Retrieved from [USPTO database]
- [Additional patent filings and scientific publications relevant to the chemical class or therapeutic area]
